FDA Grants Breakthrough Device Designation to pTau 217 Blood Test for Alzheimer Disease Detection
The FDA granted a pTau 217 blood test (SpearBio), an assessment to detect Alzheimer disease in patients, a breakthrough device designation. According to experts, this designation recognizes the test’s potential to address a critical unmet need for the …